Compliance is one of the key factors for pharmaceutical companies in running a sustainable business in Japan. In our fourth installment of the Spotlight on Japan mini-series, industry specialists Ryosuke Tateishi, Mami Ohara and Rie Kuwabara, Healthcare & Life Sciences Compliance and Regulatory counsels based in Tokyo, will take a closer look at the compliance issues in the Japanese pharmaceutical market, including enforcement trends, key compliance areas and requirements for establishing an appropriate compliance system.
Podden och tillhörande omslagsbild på den här sidan tillhör
Baker McKenzie. Innehållet i podden är skapat av Baker McKenzie och inte av,
eller tillsammans med, Poddtoppen.
